Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,428 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term Outcomes following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) versus Pancreatic Ductal Adenocarcinoma (PDAC): A Propensity-score Matched Analysis.
Lucocq J, Halle-Smith J, Haugk B, Joseph N, Hawkyard J, Lye J, Parkinson D, White S, Mownah O, Zen Y, Menon K, Furukawa T, Inoue Y, Hirose Y, Sasahira N, Mittal A, Samra J, Sheen A, Feretis M, Balakrishnan A, Ceresa C, Davidson B, Pande R, Dasari BVM, Tanno L, Karavias D, Helliwell J, Young A, Marks K, Nunes Q, Urbonas T, Silva M, Gordon-Weeks A, Barrie J, Gomez D, van Laarhoven S, Nawara H, Doyle J, Bhogal R, Harrison E, Roalso M, Ciprani D, Aroori S, Ratnayake B, Koea J, Capurso G, Bellotti R, Stättner S, Alsaoudi T, Bhardwaj N, Rajesh S, Jeffery F, Connor S, Cameron A, Jamieson N, Soreide K, Gill AJ, Roberts K, Pandanaboyana S. Lucocq J, et al. Among authors: inoue y. Ann Surg. 2024 Mar 22. doi: 10.1097/SLA.0000000000006272. Online ahead of print. Ann Surg. 2024. PMID: 38516777
Analysis of prognostic factors for borderline resectable pancreatic cancer after neoadjuvant chemotherapy: the importance of CA19-9 decrease in patients with elevated pre-chemotherapy CA19-9 levels.
Ono Y, Inoue Y, Ito H, Sasaki T, Takeda T, Ozaka M, Sasahira N, Hiratsuka M, Matsueda K, Oba A, Sato T, Saiura A, Takahashi Y. Ono Y, et al. Among authors: inoue y. HPB (Oxford). 2023 Jan;25(1):100-108. doi: 10.1016/j.hpb.2022.09.012. Epub 2022 Oct 4. HPB (Oxford). 2023. PMID: 36280425 Free article.
[No title available]
[No authors listed] [No authors listed] PMID: 37173612
Outcomes of lung oligometastasis in pancreatic cancer.
Takeda T, Sasaki T, Ichinose J, Inoue Y, Okamoto T, Mie T, Furukawa T, Kasuga A, Oba A, Matsuura Y, Nakao M, Ozaka M, Mun M, Takahashi Y, Sasahira N. Takeda T, et al. Among authors: inoue y. Jpn J Clin Oncol. 2023 Dec 7;53(12):1144-1152. doi: 10.1093/jjco/hyad111. Jpn J Clin Oncol. 2023. PMID: 37609670
Risk of Recurrence after Surgical Resection for Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasia (IPMN) with Patterns of Distribution and Treatment: An International, Multicentre, Observational Study.
Lucocq J, Hawkyard J, Robertson FP, Haugk B, Lye J, Parkinson D, White S, Mownah O, Zen Y, Menon K, Furukawa T, Inoue Y, Hirose Y, Sasahira N, Feretis M, Balakrishnan A, Zelga P, Ceresa C, Davidson B, Pande R, Dasari B, Tanno L, Karavias D, Helliwell J, Young A, Nunes Q, Urbonas T, Silva M, Gordon-Weeks A, Barrie J, Gomez D, van Laarhoven S, Doyle J, Bhogal R, Harrison E, Roalso M, Ciprani D, Aroori S, Ratnayake B, Koea J, Capurso G, Bellotti R, Stättner S, Alsaoudi T, Bhardwaj N, Jeffery F, Connor S, Cameron A, Jamieson N, Sheen A, Mittal A, Samra J, Gill A, Roberts K, Soreide K, Pandanaboyana S. Lucocq J, et al. Among authors: inoue y. Ann Surg. 2023 Oct 24. doi: 10.1097/SLA.0000000000006144. Online ahead of print. Ann Surg. 2023. PMID: 37873663
A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of multidisciplinary treatment.
Omiya K, Maekawa A, Oba A, Inoue Y, Hirose Y, Kobayashi K, Ono Y, Sato T, Ichinose J, Sasaki T, Ozaka M, Wu YHA, Hiratsuka M, Matsueda K, Mun M, Sasahira N, Ito H, Saiura A, Takahashi Y. Omiya K, et al. Among authors: inoue y. Br J Surg. 2024 Jan 3;111(1):znad417. doi: 10.1093/bjs/znad417. Br J Surg. 2024. PMID: 38215237 No abstract available.
Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN study.
Lucocq J, Hawkyard J, Haugk B, Mownah O, Menon K, Furukawa T, Inoue Y, Hirose Y, Sasahira N, Feretis M, Balakrishnan A, Ceresa C, Davidson B, Pande R, Dasari B, Tanno L, Karavias D, Helliwell J, Young A, Nunes Q, Urbonas T, Silva M, Gordon-Weeks A, Barrie J, Gomez D, Van Laarhoven S, Robertson F, Nawara H, Doyle J, Bhogal R, Harrison E, Roalso M, Ciprani D, Aroori S, Ratnayake B, Koea J, Capurso G, Bellotti R, Stättner S, Alsaoudi T, Bhardwaj N, Rajesh S, Jeffery F, Connor S, Cameron A, Jamieson N, Sheen A, Mittal A, Samra J, Gill A, Roberts K, Søreide K, Pandanaboyana S. Lucocq J, et al. Among authors: inoue y. Br J Surg. 2024 Apr 3;111(4):znae100. doi: 10.1093/bjs/znae100. Br J Surg. 2024. PMID: 38659247
8,428 results